platinum doublet Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 2 (1)
Phase 3 (1)

Interventional (2)

Hoffmann-La Roche (1)
National Cancer Institute (NCI) (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadhiv test

I am/have/hadimmunohistochemistry

I am/have/hadHIV Infection

I am/have/hadcarcinoma

I am/have/hadsquamous non-small cell lung carcinoma

I am/have/hadstage iia lung cancer ajcc v7

I am/have/hadstage iiia lung squamous cell carcinoma ajcc v7

I am/have/hadsquamous cell carcinoma of lung

I am/have/hadnon-small cell lung cancer

I am/have/hadstage ii lung squamous cell carcinoma ajcc v7

I am/have/hadantiretroviral therapy

I am/have/hadneutrophil count

I am/have/hadstage iia lung squamous cell carcinoma ajcc v7

I am/have/hadsquamous cell carcinoma

I am/have/hadhepatitis

I am/have/hadcancer chemotherapy

I am/have/hadsquamous non-small cell lung cancer

I am/have/hadegfr exon 19 deletion

I am/have/hadEGFR

I am/have/hadnon-small cell carcinoma

added new label for I am/have/had

I am looking for

I am looking formonoclonal antibodies

I am looking forcisplatin

I am looking forimmunomodulators

I am looking forcarboplatin

I am looking forpembrolizumab

I am looking foratezolizumab

I am looking forgemcitabine

I am looking formonoclonal protein

I am looking forpaclitaxel

I am looking forpemetrexed

added new label for I am looking for

Advanced Filters

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

A Study of the Efficacy and Safety of RO7198457 in Combination With Atezolizumab Versus Atezolizumab Alone Following Adjuvant Platinum-Doublet Chemotherapy in Participants Who Are ctDNA Positive After Surgical Resection of Stage II-III Non-Small Cell Lung Cancer

This study will evaluate the efficacy, safety, pharmacokinetics, immunogenicity and biomarkers of RO7198457 plus atezolizumab compared with atezolizumab alone in patients with Stage II-III non-small cell lung cancer (NSCLC) who are circulating tumor DNA (ctDNA) positive following surgical resection and have received standard-of-care adjuvant platinum-doublet chemotherapy.

hiv test

small cell lung cancer

immunomodulators

cancer

ct scan

0 views
19 Feb, 2024

Phase 3
For Seniors
For adults
Recruiting in 1000s
Interventional Study
all
Recruiting

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

monoclonal antibodies

cisplatin

immunohistochemistry

stage iiia lung squamous cell carcinoma ajcc v7

HIV Infection

0 views
19 Feb, 2024